Compounds > sulfinpyrazone
Page last updated: 2024-08-16

sulfinpyrazone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

sulfinpyrazone has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FitzGerald, GA; Pedersen, AK1
O'Flaherty, JT; Stimler, NP1
Chignard, M; Lefort, J; Vargaftig, BB; Wal, F1
Benveniste, J; Chignard, M; Lefort, J; Vargaftig, BB; Wal, F1
Chignard, M; Lefort, J; Medeiros, MC; Vargaftig, BB; Wal, F1
Kelefiotis, D; Vakirtzi-Lemonias, C1

Reviews

1 review(s) available for sulfinpyrazone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Background and present status of research on platelet-activating factor (PAF-acether).
    Annals of the New York Academy of Sciences, 1981, Volume: 370

    Topics: Animals; Basophils; Blood Platelets; Chromatography, Thin Layer; Dogs; Guinea Pigs; Humans; Leukocytes; Lipase; Lysophosphatidylcholines; Macrophages; Neutrophils; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Sulfinpyrazone

1981

Other Studies

5 other study(ies) available for sulfinpyrazone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
    Clinical pharmacology and therapeutics, 1985, Volume: 37, Issue:1

    Topics: Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2

1985
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
    The American journal of pathology, 1983, Volume: 113, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2

1983
Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
    European journal of pharmacology, 1982, Feb-19, Volume: 78, Issue:1

    Topics: Adenosine Diphosphate; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Guinea Pigs; In Vitro Techniques; Lysophosphatidylcholines; Muscle Contraction; Platelet Activating Factor; Platelet Count; Sulfinpyrazone

1982
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
    Agents and actions, 1982, Volume: 12, Issue:5-6

    Topics: Animals; Blood Platelets; Bronchi; Guinea Pigs; Platelet Activating Factor; Platelet Aggregation; Reserpine; Stereoisomerism; Sulfinpyrazone

1982
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.
    Agents and actions, 1993, Volume: 40, Issue:3-4

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cells; Chlorpromazine; Erythrocyte Count; Histamine Antagonists; Leukocyte Count; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Count; Promethazine; Serotonin Antagonists; Sulfinpyrazone

1993